The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Open accessAbstract
Epigenetic dysregulation is a defining feature of tumorigenesis that is implicated in immune escape 1,2. Here, to identify factors that modulate the immune sensitivity of cancer cells, we performed in vivo CRISPR-Cas9 screens targeting 936 chromatin regulators in mouse tumour models treated with immune checkpoint blockade. We identified the H3K9 methyltransferase SETDB1 and other members of the HUSH and KAP1 complexes as mediators of immune escape 3-5. We also found that amplification of SETDB1 (1q21.3) in human tumours is associated with immune exclusion and resistance to immune checkpoint blockade. SETDB1 represses broad domains, primarily within the open genome compartment. These domains are enriched for transposable elements (TEs) and immune clusters associated with segmental duplication events, a central mechanism of genome evolution 6. SETDB1 loss derepresses latent TE-derived regulatory elements, immunostimulatory genes, and TE-encoded retroviral antigens in these regions, and triggers TE-specific cytotoxic T cell responses in vivo. Our study establishes SETDB1 as an epigenetic checkpoint that suppresses tumour-intrinsic immunogenicity, and thus represents a candidate target for immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Targeting specific H3K9 methyltransferases, such as SUV39H1 and SETDB1, has been shown to enhance immunotherapy responses in various cancer models.”
From Multi-omics analysis identifies glioblastoma dependency on H3K9me3 methyltransferase activity (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SETDB1 targeting can promote cytotoxic T cell-based immunotherapy in cancer mouse models24.”
From Multi-omics analysis identifies glioblastoma dependency on H3K9me3 methyltransferase activity (2025) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to other recently characterized immune evasion genes 4,8,45 , tumour-specific loss of TBK1 did not result in dramatic remodeling of the immune compartment.”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationThe Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
Lieberman-Aiden, E., van Berkum, N. L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., Amit, I., Lajoie, B. R., Sabo, P. J., Dorschner, M. O., et al. (2009) · Science · doi:10.1126/science.1181369 · Cited by 8,898
Self-citationSCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Cited by
Sorted by citations
Items 201–300 of 372
Epigenetic markers and therapeutic targets for metastasis
Kravitz, C. J., Yan, Q., & Nguyen, D. X. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10109-y · Cited by 9
Obata, H., Tsuji, A. B., Sudo, H., Sugyo, A., Hashiya, K., Ikeda, H., Itoh, M., Minegishi, K., Nagatsu, K., Ogawa, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16111526 · Cited by 8
Reprogramming Cancer Cells to Antigen-presenting Cells
Ferreira, A. G., Zimmermannová, O., Kurochkin, I., Ascic, E., Åkerström, F., & Pereira, C. (2023) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4881 · Cited by 9
SETDB1: Progress and prospects in cancer treatment potential and inhibitor research
Ma, T., Xu, F., Hou, Y., Shu, Y., Zhao, Z., Zhang, Y., Bai, L., Lu, F., & Zhong, L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107219 · Cited by 7
Discovery platforms for RNA therapeutics
Ciucci, G., Braga, L., & Zacchigna, S. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16424 · Cited by 8
Epigenetic mechanisms in melanoma development and progression
Joo, H., Olea, X. D., Zhuang, A., Zheng, B., Kim, H., & Ronai, Z. A. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.007 · Cited by 9
SETDB1, a new target for immunotherapy
Harjes, U. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00373-x · Cited by 8
Using epigenetic modifiers to target cancer stem cell immunoevasion
Galassi, C., Vitale, I., & Galluzzi, L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.11.003 · Cited by 8
Molina-Olvera, G., Rivas-Ortiz, C. I., Schcolnik‐Cabrera, A., Castillo-Rodal, A. I., & López‐Vidal, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094525 · Cited by 8
Yamamoto, Y., Shimada, S., Akiyama, Y., Tsukihara, S., Sugimoto, R., Kabashima, A., Tokunaga, M., Kinugasa, Y., Kawakami, Y., & Tanaka, S. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-01969-w · Cited by 8
Metabolism and Immune Suppressive Response in Liver Cancer
Caini, P., & Carloni, V. (2025) · Biomedicines · doi:10.3390/biomedicines13061461 · Cited by 8
Netie: inferring the evolution of neoantigen–T cell interactions in tumors
Lu, T., Park, S., Han, Y., Wang, Y., Hubert, S. M., Futreal, P. A., Wistuba, I. I., Heymach, J. V., Reuben, A., Zhang, J. J., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01644-7 · Cited by 7
SETDB1 as a cancer target: challenges and perspectives in drug design
Hassanie, H., Penteado, A. B., de Almeida, L. C., Calil, R. L., Emery, F. D. S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00366c · Cited by 7
Structure and Methyl-lysine Binding Selectivity of the HUSH Complex Subunit MPP8
Nikolopoulos, N., Oda, S.-I., Prigozhin, D. M., & Modis, Y. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168890 · Cited by 10
Epigenetic regulation of immune cells in central nervous system: from steady state to pathology
Zhao, L., Schepp, C. L., Iskandar, M., Tao, Y., & Dey, M. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106005 · Cited by 6
Wu, M., Yang, S., Yang, Z., Fan, J., Lomeli, S. H., Dharanipragada, P., Moriceau, G., Damoiseaux, R. D., Kelley, M. C., Granada, C. N. P., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.001 · Cited by 6
Epigenetic regulation of varicella-zoster virus infection: a systematic synthesis of mechanisms
Peng, L., Song, H., Li, T., Ma, Y., Yan, C., Sun, K., Han, C., & Yuan, H. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003912 · Cited by 6
Cancer drug response and resistance: molecular mechanisms and combating strategies
Cheng, X., Xu, M., Wei, J., & Cao, C. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02924-w · Cited by 10
Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens
Lee, T. W., Hunter, F. W., Tsai, P., Print, C. G., Wilson, W. R., & Jamieson, S. M. F. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00664-5 · Cited by 8
Yang, H., Sui, L., Cai, C., Chu, H., & Diao, Y. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01358-8 · Cited by 6
Cen, Y., Zhang, L., Liu, M.-P., Xiang, C., Lu, T.-X., Xue, Y., & Zheng, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140527 · Cited by 6
Reversing epigenetic repression of transposable elements for improving tumor immunogenicity
Wang, X., Zhang, Q., & Cao, X. (2022) · 癌症：英文版 · doi:10.1002/cac2.12261 · Cited by 5
Functional dissection of N-terminal nuclear trafficking signals of SETDB1
Eom, J., Jeon, K., Park, J. S., & Kang, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1069765 · Cited by 6
Epigenetics behind tumor immunology: a mini review
Musella, M., Manduca, N., Maccafeo, E., & Sistigu, A. (2023) · Oncogene · doi:10.1038/s41388-023-02791-7 · Cited by 5
Wang, Y., Khalil, A., Kamar, A., Du, M., Dinh, T., McFarland, C. D., & Wang, Z. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1304425 · Cited by 6
Wang, X., Jin, J., Yan, H., Liu, J., Huang, S., Bai, H., Guo, M., Cheng, X., Deng, T., Ba, Y., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ado4370 · Cited by 7
CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasion
Huber, A., Djajawi, T. M., Rivera, S., Vervoort, S. J., & Kearney, C. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116738 · Cited by 5
Hasan, A. U., Serada, S., Sato, S., Obara, M., Hirata, S., Nagase, Y., Kondo, Y., & Taira, E. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30643 · Cited by 5
Liang, Z., Xu, Y., & Li, C. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103874 · Cited by 5
In Vivo Identification of H3K9me2/H3K79me3 as an Epigenetic Barrier to Carcinogenesis
Piro, M. C., Gasperi, V., Stefano, A. D., Anemona, L., Cenciarelli, C. R., Montanaro, M., Mauriello, A., Catani, M. V., Terrinoni, A., & Gambacurta, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512158 · Cited by 5
He, M. Y., Tong, K. I., Liu, T., Hawkins, R. W., Shelton, V., Zeng, Y., Bakhtiari, M., Xiao, Y., Zheng, G., Sakhdari, A., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02325-4 · Cited by 5
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms
DiNapoli, S. E., Martinez-McFaline, R., Shen, H., Doane, A. S., Perez, A. R., Verma, A., Simon, A., Nelson, I. S., Balgobin, C. A., Bourque, C., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.814216 · Cited by 5
Brodeur, M. N., Dopeso, H., Zhu, Y., Longhini, A. L. F., Gazzo, A. M., Sun, S., Koche, R. P., Qu, R., Hamard, P.-J., Bykov, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.08.552544 · Cited by 5
Bond, D. R., Burnard, S. M., Uddipto, K., Hunt, K. V., Harvey, B. M., Reinhardt, L. S., Lawlor-O’Neill, C., Roper, E. A., Humphries, S., Murray, H. C., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02693-5 · Cited by 4
Padelli, M., Desterke, C., Devocelle, A., Uzan, G., Lemoine, A., & Giron‐Michel, J. (2026) · Cellular Oncology · doi:10.1007/s13402-025-01157-3 · Cited by 4
Lockbaum, G. J., Lynes, M. M., Shen, S. A., Liu, J. X., Holt, N., Nayak, S. P., Knockenhauer, K. E., Yao, S., Sickmier, E. A., Raman, A., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08005-y · Cited by 4
Self-citationSorial, M. N., Han, J. X., Koh, M. J., Boussi, L. S., Li, S., Duan, R., Lu, J., Lei, M. M., MacVicar, C. T., Freydman, J., et al. (2025) · British Journal of Haematology · doi:10.1111/bjh.20063 · Cited by 4
The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis
Chang, Y. A., & Goyama, S. (2025) · Cancer Science · doi:10.1111/cas.70116 · Cited by 4
Shi, X., An, Z., Cheng, S., Yao, J., Zhang, Y., Zhang, L., Cheng, X., Cui, Y., & Wang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117135 · Cited by 5
Li, Q., Zhang, Z., Wang, Y., Peng, X., Fang, Y., Zhang, Y., Chen, L., Huang, T., Yang, Z., Li, C., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-3231 · Cited by 4
Voutsadakis, I. A. (2023) · Gene · doi:10.1016/j.gene.2023.147179 · Cited by 4
Chen, M., Nie, Z., Huang, D., Gao, Y., Cao, H., Zheng, L., & Zhang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192428 · Cited by 4
Proceedings of the inaugural Dark Genome Symposium: November 2022
Boeke, J. D., Burns, K. H., Chiappinelli, K. B., Classon, M., Coffin, J. M., DeCarvalho, D., Dukes, J. D., Greenbaum, B. D., Kassiotis, G., Knutson, S. K., et al. (2023) · Mobile DNA · doi:10.1186/s13100-023-00306-5 · Cited by 3
Wang, X., Cheng, S., Xu, Y., Zheng, T., Ling, C., & Du, J. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70214 · Cited by 4
Börzsei, R., Bayarsaikhan, B., Zsidó, B. Z., Lontay, B., & Hetényi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911316 · Cited by 4
The cancer epigenome: Non‐cell autonomous player in tumor immunity
Kato, S., Maeda, Y., Sugiyama, D., Watanabe, K., Nishikawa, H., & Hinohara, K. (2022) · Cancer Science · doi:10.1111/cas.15681 · Cited by 3
Alterations of histone modifications in cancer
Saber-Ayad, M. M., Ramadan, W. S. H., & El‐Awady, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00018-x · Cited by 5
Interpreting Cis-Regulatory Interactions from Large-Scale Deep Neural Networks for GenomicsPreprint
Toneyan, S., & Koo, P. K. (2023) · bioRxiv · doi:10.1101/2023.07.03.547592 · Cited by 3
Sinha, J., Nickels, J. F., Thurm, A. R., Ludwig, C., Archibald, B. N., Hinks, M. M., Wan, J., Dong, F., & Bintu, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.13.562147 · Cited by 4
KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cellsPreprint
Lau, L., Henderson, K., Turkoz, A., Linker, S. B., Schlesinger, D., Townsley, B. T., Egan, B. S., Ragunathan, S., Rollins, R. A., Bi, X., et al. (2025) · eLife · doi:10.7554/elife.106249 · Cited by 6
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancer
Hong, D., Lyu, Y., Nayak, R., Becker, J. S., Booker, M. A., Masuzawa, K., Devos, Z., Wang, T., Saito, S., Liu, Q., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.07.023 · Cited by 5
Self-citationDemanelis, K., Leix, J., Burgess, M. A., & Nacev, B. A. (2026) · ESMO rare cancers. · doi:10.1016/j.esmorc.2026.100129 · Cited by 3
Viral mimicry acts as a tumor suppressor in colitis
Larsen, F., Jeong, W., Schep, D., Good, H. J., Shin, A. E., Zhang, L., Derouet, M., Wang, T. C., Castellani, C. A., Shooshtari, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68850-1 · Cited by 4
Akana, R. V., Yoe, J., Laveroni, O., Sun, C., Kim, Y.-M., & Jerby‐Arnon, L. (2026) · Nature Genetics · doi:10.1038/s41588-026-02561-7 · Cited by 3
Kehm, H., Zens, S., Baumann, D., Meng, Z., de Ru, A. H., Tjokrodirijo, R. T. N., Vent, C., Murawjew, O., Braun, S., Weiss, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.adr6132 · Cited by 3
Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy
Peng, C. Y., Zhou, N., Chen, T., Lei, J., Chen, C., & Zhu, S. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096311909240721160523 · Cited by 2
Zheng, J., Li, X., Gong, X., Hu, Y., & Tang, M. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-1064 · Cited by 3
Yin, C., & Song, C. (2024) · Cells · doi:10.3390/cells13242102 · Cited by 3
The silent guardian: unraveling the roles of H3K9me3 in genome maintenance
Li, Z., & Zhang, Z. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00131-x · Cited by 3
Zhang, Y., Yu, B., Tian, Y., Ren, P., Lyu, B., Fu, L., Chen, H., Li, J., & Gong, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.957059 · Cited by 3
Dai, Y., Chen, H., Pan, Y.-T., Lv, L., Wang, W., Chen, X., & Zhou, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1002781 · Cited by 3
Delaney, C. E., Fol, L., You, J. E., Gruenewald, S. B., Ferrario, E., Gasser, S. M., Moeckel, M. M., Stelzl, L., Padeken, J., & Mango, S. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.29.615660 · Cited by 3
Wang, X., Dai, L., Liu, Y., Li, C., Fan, D., Zhou, Y., Li, P., Kong, Q., & Su, J. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00490-x · Cited by 2
Targeting SETDB1 in cancer and immune regulation: Potential therapeutic strategies in cancer
Pan, B., Lin, C., Lee, G. A., & Lin, H. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12933 · Cited by 2
Verdier, E., Gaspar, N., Costa, M. E. M. D., & Marchais, A. (2025) · Oncotarget · doi:10.18632/oncotarget.28688 · Cited by 2
Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway
Li, J., Zhen, X., Liu, L., Yan, X., Wu, L., Luo, X., & Zhang, P. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108611 · Cited by 3
Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis
Tunbak, H., & Deniz, Ö. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.07.006 · Cited by 2
Nacev, B. A., Bradić, M., Woo, H. J., Richards, A. L., Kelly, C. M., Dickson, M. A., Gounder, M. M., Keohan, M. L., Chi, P., Movva, S., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012357 · Cited by 4
Shi, K., Cao, K., Yin, M., Liu, C., Xie, H., Chen, X., & Zhou, J. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02525-1 · Cited by 2
Recent insights into crosstalk between genetic parasites and their host genome
Mandal, A. K. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac032 · Cited by 2
Long, X., Li, F., Tang, S., Liu, J., Fu, Y., & Feng, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s452062 · Cited by 2
Zheng, Y., Duan, C., Yu, H., Jiang, G., Shen, H., Li, H., Wang, Z., Zhou, X., Li, X., & He, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1433094 · Cited by 2
Epigenetic Dysregulation of Retrotransposons in Cancer
Liu, K. Y., & Leung, D. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0744 · Cited by 5
Maternal histone methyltransferases antagonistically regulate monoallelic expression in C. elegansPreprint
Sands, B., Yun, S. R., Oshima, J., & Mendenhall, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.22.576748 · Cited by 2
Ning, B., Chiu, D. J., Pfefferkorn, R., Kefella, Y., Kane, E., Reyes-Ortíz, V. E., Liu, G., Zhang, S., Liu, H., Sultan, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636307 · Cited by 2
MOGAN for LUAD Subtype Classification by Integrating Three Omics Data Types
He, H., Wang, L., & Ma, M.-Y. (2025) · Cancer Innovation · doi:10.1002/cai2.160 · Cited by 1
Fan, M., Wu, J., Wu, Y., Zhang, Y., Song, M., Wei, T., Zhu, D., Jiang, L., Yu, Y., Qu, L., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151934 · Cited by 1
Self-citationSetdb1 and Atf7IP form a hetero-trimeric complex that blocks Setdb1 nuclear export
Kariapper, L. S., Marathe, I. A., Niesman, A. B., Suino-Powell, K. M., Chook, Y. M., Wysocki, V. H., & Worden, E. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110171 · Cited by 1
Sands, B., Yun, S. R., Oshima, J., & Mendenhall, A. (2025) · Nature Communications · doi:10.1038/s41467-025-66501-5 · Cited by 3
Apoptotic metabolites synthesize and inherit unique de novo L2a/L2b RNAs to prevent virus infection
Li, P., Lan, Y., Yan, X., Cao, Z., Ji, J., Deng, M., He, D., Huang, R., Qu, Y., Wu, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.11.035 · Cited by 1
Lin, Z., Chen, H., Chen, J., Huang, S., Hu, J., Zhou, C., & He, S. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02022-z · Cited by 1
Ma, J., Huang, Y., Zheng, T., Wang, H., Li, B., Liu, S., Liu, C., Chen, X., & Min, J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153815 · Cited by 1
Cancer Cell-Intrinsic Programs That Shape Tumor Immune Ecosystems
Wang, L., Guo, Y., Ma, L., & Miao, K. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i2.33 · Cited by 1
Sueyoshi, K., Kakiuchi, M., Komura, D., Katoh, H., Yamamoto, A., Kirimura, S., Onishi, I., Asakawa, A., Ishibashi, H., Ohashi, K., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117361 · Cited by 1
Huang, S., Lv, Y., Wang, Y., Duan, Y., Li, S., Guo, Y., Xie, S., Dong, C., Yang, Y., Sun, S.-K., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118982 · Cited by 1
Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan
Al-Ewaidat, O. A., & Naffaa, M. M. (2026) · Immunology · doi:10.1111/imm.70161 · Cited by 2
McDonald, J. A., Scott, L., Zuylekom, J. V., Holloway, S., Blyth, B. J., & Sutherland, K. D. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3331-1_3 · Cited by 1
Decoding Neurological Mysteries: The Potential Impact of Endogenous Retroviruses on Brain Health
Li, J., Liao, L., Liu, X., Zhu, Y., Sun, D., Zhang, C., & Jiang, Y. (2024) · Stress and Brain · doi:10.26599/sab.2023.9060005 · Cited by 1
Liu, Z., Yang, H., Chen, Z., & Jing, C. (2022) · Hereditas · doi:10.1186/s41065-022-00253-w · Cited by 1
Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse modelsPreprint
Jaeger, A. M., Stopfer, L. E., Sanders, E. A., Sandel, D. A., Freed-Pastor, W. A., Rideout, W. M., Naranjo, S., Fessenden, T. B., Winter, P. S., Kohn, R. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.30.450516 · Cited by 1
Neural Induction: the General Principle for Embryogenesis and TumorigenesisPreprint
Cao, Y. (2022) · Preprints.org · doi:10.20944/preprints202208.0203.v1
Coley, A. K., Nawrocki, C., Patel, B. K., Pankaj, A., Guo, Z., Emmett, M. J., Lang, E. R., Song, Y., Xu, K. H., Ferrone, C. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.04.570014 · Cited by 1
Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancersPreprint
Najia, M. A. T., Jha, D. K., Zhang, C., Laurent, B., Kubaczka, C., Markel, A., Li, C., Morris, V., Tompkins, A., Hensch, L. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.31.635709 · Cited by 1
Differentiation status determines tumorigenicity and immunogenicity of cancer cellsPreprint
Liu, Y., Wang, C., Li, H., & Cao, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.30.656250 · Cited by 1
RNF19B confers tumor resistance to CAR T cellsPreprint
Geiger, R., Vogel, I. A., Casagranda, A., Cattaneo, M., Morosi, L. G., Pecoraro, M., Sulheim, E., & Basso, C. (2025) · Research Square · doi:10.21203/rs.3.rs-7847831/v1 · Cited by 1
Sánchez‐Serra, S., Chicón‐Bosch, M., Martorell-Villanueva, N., Candeal, E., Jarne-Sanz, I., Bech‐Serra, J. J., Giménez-Llorente, D., Gris-Lorente, M., Monaco, P., Santana-Viera, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.23.696151 · Cited by 1
Almeida, A., Gabriel, M., Firlej, V., Jaular, L. M., Lejars, M., Cipolla, R., Vogt, N., Destouches, D., Vacherot, F., TAILLE, A. D. L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-871568/v2
Almeida, A., Gabriel, M., Firlej, V., Jaular, L. M., Lejars, M., Cipolla, R., Vogt, N., Destouches, D., Vacherot, F., TAILLE, A. D. L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-871568/v1
Alexeeva, M., Roalsø, M. T. T., & Søreide, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00027-x
Marcon, J., & Stief, C. G. (2022) · Uro-News · doi:10.1007/s00092-022-5502-0
Metadata
- Authors
- Griffin, G. K., Wu, J., Iracheta-Vellve, A., Patti, J. C., Hsu, J., Davis, T., Dele-Oni, D., Du, P. P., Halawi, A. G., Ishizuka, J. J., Kim, S. Y., Klaeger, S., Knudsen, N. H., Miller, B. C., Nguyen, T. H., Olander, K. E., Papanastasiou, M., Rachimi, S., Robitschek, E. J., Schneider, E. M., Yeary, M. D., Zimmer, M. D., Jaffe, J. D., Carr, S. A., Doench, J. G., Haining, W. N., Yates, K. B., Manguso, R. T., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Manguso, Robert T.
- Bernstein, Bradley E.
- ORCID
- Griffin, Gabriel K.
- Wu, Jingyi
- Iracheta-Vellve, Arvin
- Patti, James C.
- Hsu, Jeffrey
- Dele-Oni, Deborah
- Du, Peter P.
- Halawi, Aya G.
- Ishizuka, Jeffrey J.
- Kim, Sarah Y.
- Klaeger, Susan
- Knudsen, Nelson H.
- Miller, Brian C.
- Nguyen, Tung H.
- Olander, Kira E.
- Papanastasiou, Malvina
- Rachimi, Suzanna
- Robitschek, Emily J.
- Schneider, Emily M.
- Yeary, Mitchell D.
- Zimmer, Margaret D.
- Jaffe, Jacob D.
- Carr, Steven A.
- Doench, John G.
- Haining, W. Nicholas
- Yates, Kathleen B.
- Manguso, Robert T.
- Bernstein, Bradley E.
- Venue
- Nature
- Published
- 2021-05-05
- Volume
- 595
- Issue
- 7866
- Pages
- 309-314
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC9166167
- OpenAlex
- W3158155618
- Cited by
- 370
- References
- 61
- Citations by year
- 2026: 57 · 2025: 78 · 2024: 77 · 2023: 69 · 2022: 70 · 2021: 19
- FWCI
- 21.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (DP1CA216873, K08CA245112, U24CA210986, U01CA214125)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- SETDB1, H3K9 methyltransferase, epigenetic silencing, tumor immunogenicity, immune evasion, immune checkpoint blockade, transposable elements, segmental duplication, retroviral antigens, cytotoxic T lymphocytes, HUSH complex, chromatin regulators, immunotherapy targets
- MeSH terms
- Animals, Antigens, Viral, Chromatin, Disease Models, Animal, DNA Transposable Elements, Female, Humans, Neoplasms, Histone-Lysine N-Methyltransferase, T-Lymphocytes, Cytotoxic, Histocompatibility Antigens Class I, Gene Silencing, Mice, Programmed Cell Death 1 Receptor, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
